1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

LifeSprout, Inc.

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2015

Location

Baltimore MD US

Primary Industry

Biotechnology

About

Founded in 2015 and based in Maryland, US, LifeSprout, Inc. is a biotechnology company that creates synthetic soft tissue substitutes for aesthetic and reconstructive medicine used by cancer and trauma patients. The company's Regenerative Matrix platform develops products that look and feel like the body's own tissues for patients with soft tissue losses from aging, cancer, metabolic disease, and orphan indications. It also offers Lumina, which is an aesthetic filler that enables immediate, natural restoration with biostimulatory effects.
Current Investors
Kairos Ventures, Maryland Technology Development Corporation, Triskelion Capital

Request a demo to show more

Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Molecular Science, Genetics & Gene Therapy, Pharmaceutical Research & Development
Website
www.lifesproutbio.com
Verticals
HealthTech
Company Stage
Series A
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.